CD8+ immunodominance among Epstein-Barr virus lytic cycle antigens directly reflects the efficiency of antigen presentation in lytically infected cells

被引:114
作者
Pudney, VA [1 ]
Leese, AM [1 ]
Rickinson, AB [1 ]
Hislop, AD [1 ]
机构
[1] Univ Birmingham, Inst Canc Studies, Birmingham B15 2TT, W Midlands, England
基金
英国医学研究理事会;
关键词
D O I
10.1084/jem.20041542
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Antigen immunodominance is an unexplained feature of CD8(+) T cell responses to herpesviruses, which are agents whose lytic replication involves the sequential expression of immediate early (IE), early (E), and late (L) proteins. Here, we analyze the primary CD8 response to Epstein-Barr virus (EBV) infection for reactivity to 2 IE proteins, 11 representative E proteins, and 10 representative L proteins, across a range of HLA backgrounds. Responses were consistently skewed toward epitopes in IE and a subset of E proteins, with only occasional responses to novel epitopes in L proteins. CD8(+) T cell clones to representative IE, E, and L epitopes were assayed against EBV-transformed lymphoblastoid cell lines (LCLs) containing lytically infected cells. This showed direct recognition of lytically infected cells by all three sets of effectors but at markedly different levels, in the order IE > E > L, indicating that the efficiency of epitope presentation falls dramatically with progress of the lytic cycle. Thus, EBV lytic cycle antigens display a hierarchy of immunodominance that directly reflects the efficiency of their presentation in lytically infected cells; the CD8(+) T cell response thereby focuses on targets whose recognition leads to maximal biologic effect.
引用
收藏
页码:349 / 360
页数:12
相关论文
共 59 条
[1]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[2]   Longitudinal dynamics of antigen-specific CD8+ cytotoxic T lymphocytes following primary Epstein-Barr virus infection [J].
Bharadwaj, M ;
Burrows, SR ;
Burrows, JM ;
Moss, DJ ;
Catalina, M ;
Khanna, R .
BLOOD, 2001, 98 (08) :2588-2589
[3]   Human CD8+ T cell responses to EBV EBNA1:: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing [J].
Blake, N ;
Lee, S ;
Redchenko, I ;
Thomas, W ;
Steven, N ;
Leese, A ;
Steigerwald-Mullen, P ;
Kurilla, MG ;
Frappier, L ;
Rickinson, A .
IMMUNITY, 1997, 7 (06) :791-802
[4]   SELECTION OF RECOMBINANT VACCINIA VIRUSES ON THE BASIS OF PLAQUE-FORMATION [J].
BLASCO, R ;
MOSS, B .
GENE, 1995, 158 (02) :157-162
[5]   SPECIFIC CYTOTOXIC T-LYMPHOCYTES RECOGNIZE THE IMMEDIATE-EARLY TRANSACTIVATOR ZTA OF EPSTEIN-BARR-VIRUS [J].
BOGEDAIN, C ;
WOLF, H ;
MODROW, S ;
STUBER, G ;
JILG, W .
JOURNAL OF VIROLOGY, 1995, 69 (08) :4872-4879
[6]   Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus in vivo [J].
Callan, MFC ;
Tan, L ;
Annels, N ;
Ogg, GS ;
Wilson, JDK ;
O'Callaghan, CA ;
Steven, N ;
McMichael, AJ ;
Rickinson, AB .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (09) :1395-1402
[7]   Differential evolution and stability of epitope-specific CD8+ T cell responses in EBV infection [J].
Catalina, MD ;
Sullivan, JL ;
Bak, KR ;
Luzuriaga, K .
JOURNAL OF IMMUNOLOGY, 2001, 167 (08) :4450-4457
[8]   VACCINIA VIRUS EXPRESSION VECTOR - COEXPRESSION OF BETA-GALACTOSIDASE PROVIDES VISUAL SCREENING OF RECOMBINANT VIRUS PLAQUES [J].
CHAKRABARTI, S ;
BRECHLING, K ;
MOSS, B .
MOLECULAR AND CELLULAR BIOLOGY, 1985, 5 (12) :3403-3409
[9]   The nature of the MHC class I peptide loading complex [J].
Cresswell, P ;
Bangia, N ;
Dick, T ;
Diedrich, G .
IMMUNOLOGICAL REVIEWS, 1999, 172 :21-28
[10]   Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells [J].
Delecluse, HJ ;
Hilsendegen, T ;
Pich, D ;
Zeidler, R ;
Hammerschmidt, W .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (14) :8245-8250